{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T11:58:04Z","timestamp":1787313484884,"version":"build-2736575974"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T00:00:00Z","timestamp":1758067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T00:00:00Z","timestamp":1758067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Research contract from Canopy Growth Corporation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol."],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1038\/s41386-025-02232-x","type":"journal-article","created":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T16:22:04Z","timestamp":1758126124000},"page":"1827-1835","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Effect of caffeine and cannabidiol (CBD) co-administration on \u03949-tetrahydrocannabinol (\u03949-THC) subjective effects, performance impairment, and pharmacokinetics"],"prefix":"10.1038","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1077-0394","authenticated-orcid":false,"given":"Justin C.","family":"Strickland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-6467-6287","authenticated-orcid":false,"given":"Hayleigh E.","family":"Tilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noah M.","family":"Patton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Vandrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Austin Zamarripa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2859-116X","authenticated-orcid":false,"given":"Tory R.","family":"Spindle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dustin C.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia L.","family":"Bergeria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Wolinsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jost","family":"Klawitter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Sempio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Campos-Palomino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Christians","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew T.","family":"Feldner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica G.","family":"Irons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel O.","family":"Bonn-Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,17]]},"reference":[{"key":"2232_CR1","unstructured":"Business Insider. I tried one of the first caffeinated cannabis drinks, and it gave me a giddy buzz. 2021. https:\/\/www.businessinsider.com\/i-drank-caffeinated-cannabis-seltzer-was-perfect-for-going-out-2021-8."},{"key":"2232_CR2","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1111\/j.1476-5381.2011.01554.x","volume":"165","author":"LV Panlilio","year":"2012","unstructured":"Panlilio LV, Ferr\u00e9 S, Yasar S, Thorndike EB, Schindler CW, Goldberg SR. Combined effects of THC and caffeine on working memory in rats. Br J Pharm. 2012;165:2529\u201338.","journal-title":"Br J Pharm"},{"key":"2232_CR3","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/j.1369-1600.2010.00258.x","volume":"16","author":"Z Justinov\u00e1","year":"2011","unstructured":"Justinov\u00e1 Z, Ferr\u00e9 S, Redhi GH, Mascia P, Stroik J, Quarta D, et al. Reinforcing and neurochemical effects of cannabinoid CB1 receptor agonists, but not cocaine, are altered by an adenosine A2A receptor antagonist. Addiction Biol. 2011;16:405\u201315.","journal-title":"Addiction Biol"},{"key":"2232_CR4","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1111\/j.1476-5381.2010.00723.x","volume":"160","author":"S Ferr\u00e9","year":"2010","unstructured":"Ferr\u00e9 S, Llu\u00eds C, Justinova Z, Quiroz C, Orru M, Navarro G, et al. Adenosine\u2013cannabinoid receptor interactions. Implications for striatal function. Br J Pharm. 2010;160:443\u201353.","journal-title":"Br J Pharm"},{"key":"2232_CR5","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1111\/bph.12970","volume":"172","author":"S Ferreira","year":"2015","unstructured":"Ferreira S, Gon\u00e7alves F, Marques J, Tom\u00e9 \u00c2R, Rodrigues R, Nunes-Correia I, et al. Presynaptic adenosine A2A receptors dampen cannabinoid CB 1 receptor-mediated inhibition of corticostriatal glutamatergic transmission. Br J Pharm. 2015;172:1074\u201386.","journal-title":"Br J Pharm"},{"key":"2232_CR6","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.brainres.2012.04.051","volume":"1476","author":"MT Tebano","year":"2012","unstructured":"Tebano MT, Martire A, Popoli P. Adenosine A2A\u2013cannabinoid CB1 receptor interaction: an integrative mechanism in striatal glutamatergic neurotransmission. Brain Res. 2012;1476:108\u201318.","journal-title":"Brain Res"},{"key":"2232_CR7","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1038\/npp.2017.12","volume":"43","author":"E Moreno","year":"2018","unstructured":"Moreno E, Chiarlone A, Medrano M, Puigdell\u00edvol M, Bibic L, Howell LA, et al. Singular location and signaling profile of adenosine A2A-cannabinoid CB1 receptor heteromers in the dorsal striatum. Neuropsychopharmacology. 2018;43:964\u201377.","journal-title":"Neuropsychopharmacology"},{"key":"2232_CR8","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1002\/cpdd.950","volume":"10","author":"C Thai","year":"2021","unstructured":"Thai C, Tayo B, Critchley D. A phase 1 open-label, fixed-sequence pharmacokinetic drug interaction trial to investigate the effect of cannabidiol on the CYP1A2 Probe caffeine in healthy subjects. Clin Pharm Drug Dev. 2021;10:1279\u201389.","journal-title":"Clin Pharm Drug Dev"},{"key":"2232_CR9","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1037\/pha0000691","volume":"32","author":"ML Ferretti","year":"2024","unstructured":"Ferretti ML, Gustin ND, Sokol CM, Zamarripa CA, Feldner MT, Bonn-Miller MO, et al. A preliminary investigation of the simultaneous effects of cannabidiol and caffeine. Exp Clin Psychopharmacol. 2024;32:475.","journal-title":"Exp Clin Psychopharmacol"},{"key":"2232_CR10","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1002\/cpt.2973","volume":"114","author":"S Bansal","year":"2023","unstructured":"Bansal S, Zamarripa CA, Spindle TR, Weerts EM, Thummel KE, Vandrey R, et al. Evaluation of cytochrome P450-mediated cannabinoid-drug interactions in healthy adult participants. Clin Pharm Therapeutics. 2023;114:693\u2013703.","journal-title":"Clin Pharm Therapeutics"},{"key":"2232_CR11","doi-asserted-by":"publisher","first-page":"e2254752","DOI":"10.1001\/jamanetworkopen.2022.54752","volume":"6","author":"CA Zamarripa","year":"2023","unstructured":"Zamarripa CA, Spindle TR, Surujunarain R, Weerts EM, Bansal S, Unadkat JD, et al. Assessment of orally administered \u03949-tetrahydrocannabinol when coadministered with cannabidiol on \u03949-tetrahydrocannabinol pharmacokinetics and pharmacodynamics in healthy adults: a randomized clinical trial. JAMA Netw Open. 2023;6:e2254752\u2013e52.","journal-title":"JAMA Netw Open"},{"key":"2232_CR12","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1517\/17425255.1.4.641","volume":"1","author":"U Christians","year":"2005","unstructured":"Christians U, Schmitz V, Haschke M. Functional interactions between P-glycoprotein and CYP3A in drug metabolism. Expert Opin drug Metab Toxicol. 2005;1:641\u201354.","journal-title":"Expert Opin drug Metab Toxicol"},{"key":"2232_CR13","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1124\/jpet.105.098541","volume":"317","author":"H-J Zhu","year":"2006","unstructured":"Zhu H-J, Wang J-S, Markowitz JS, Donovan JL, Gibson BB, Gefroh HA, et al. Characterization of P-glycoprotein inhibition by major cannabinoids from marijuana. J Pharm Exp Therapeutics. 2006;317:850\u201357.","journal-title":"J Pharm Exp Therapeutics"},{"key":"2232_CR14","unstructured":"Food and Drug Administration. Assessment of Abuse Potential of Drugs. (Food and Drug Administration, 2017)."},{"key":"2232_CR15","unstructured":"Spielberger, C. D., Gorsuch, R. L. & Lushene, R. E. The State-Trait Anxiety Inventory (Test Manual). Palo Alto, California: Consulting Psychologists Press, 1970."},{"key":"2232_CR16","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1093\/arclin\/12.1.29","volume":"12","author":"CR Reynolds","year":"1997","unstructured":"Reynolds CR. Forward and backward memory span should not be combined for clinical analysis. Arch Clin Neuropsychol. 1997;12:29\u201340.","journal-title":"Arch Clin Neuropsychol"},{"key":"2232_CR17","doi-asserted-by":"publisher","first-page":"463","DOI":"10.3758\/BF03203313","volume":"14","author":"DR McLeod","year":"1982","unstructured":"McLeod DR, Griffiths RR, Bigelow GE, Yingling J. An automated version of the digit symbol substitution test. Behav Res Methods Instrum. 1982;14:463\u201366.","journal-title":"Behav Res Methods Instrum"},{"key":"2232_CR18","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1177\/02698811211021583","volume":"35","author":"TR Spindle","year":"2021","unstructured":"Spindle TR, Martin EL, Grabenauer M, Woodward T, Milburn MA, Vandrey R. Assessment of cognitive and psychomotor impairment, subjective effects, and blood THC concentrations following acute administration of oral and vaporized cannabis. J Psychopharmacol. 2021;35:786\u2013803.","journal-title":"J Psychopharmacol"},{"key":"2232_CR19","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.jsr.2011.06.004","volume":"42","author":"DR Mayhew","year":"2011","unstructured":"Mayhew DR, Simpson HM, Wood KM, Lonero L, Clinton KM, Johnson AG. On-road and simulated driving: concurrent and discriminant validation. J Saf Res. 2011;42:267\u201375.","journal-title":"J Saf Res"},{"key":"2232_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.964749","volume":"13","author":"CA Zamarripa","year":"2022","unstructured":"Zamarripa CA, Novak MD, Weerts EM, Vandrey R, Spindle TR. The effects of oral and vaporized cannabis alone, and in combination with alcohol, on driving performance using the STISIM driving simulator: a two-part, double-blind, double-dummy, placebo-controlled, randomized crossover clinical laboratory protocol. Front Pharm. 2022;13:964749.","journal-title":"Front Pharm"},{"key":"2232_CR21","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1093\/jat\/bkab030","volume":"46","author":"C Sempio","year":"2022","unstructured":"Sempio C, Almaraz-Quinones N, Jackson M, Zhao W, Wang GS, Liu Y, et al. Simultaneous quantification of 17 cannabinoids by LC\u2013MS-MS in human plasma. J Anal Toxicol. 2022;46:383\u201392.","journal-title":"J Anal Toxicol"},{"key":"2232_CR22","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B. 1995;57:289\u2013300.","journal-title":"J R Stat Soc Ser B"},{"key":"2232_CR23","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1002\/cpt.3381","volume":"116","author":"AA Gorbenko","year":"2024","unstructured":"Gorbenko AA, Heuberger JA, Klumpers LE, de Kam ML, Strugala PK, de Visser SJ, et al. Cannabidiol increases psychotropic effects and plasma concentrations of \u03949-tetrahydrocannabinol without improving its analgesic properties. Clin Pharm Therapeutics. 2024;116:1289\u2013303.","journal-title":"Clin Pharm Therapeutics"},{"key":"2232_CR24","doi-asserted-by":"publisher","unstructured":"Chesney E, Oliver D, Sarma A, Lamper AD, Slimani I, Lloyd M, et al. Does cannabidiol reduce the adverse effects of cannabis in schizophrenia? A randomised, double-blind, cross-over trial. Neuropsychopharmacology. 2025; https:\/\/doi.org\/10.1038\/s41386-025-02175-3. Epub ahead of print.","DOI":"10.1038\/s41386-025-02175-3"},{"key":"2232_CR25","doi-asserted-by":"crossref","unstructured":"Lo LA, Christiansen AL, Strickland JC, Pistawka CA, Eadie L, Vandrey R, et al. Does acute cannabidiol (CBD) use impair performance? A meta-analysis and comparison with placebo and delta-9-tetrahydrocannabinol (THC). Neuropsychopharmacology. 2024;49:1425\u201336.","DOI":"10.1038\/s41386-024-01847-w"},{"key":"2232_CR26","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1111\/joim.13627","volume":"293","author":"LA Lo","year":"2023","unstructured":"Lo LA, Christiansen A, Eadie L, Strickland JC, Kim DD, Boivin M, et al. Cannabidiol-associated hepatotoxicity: a systematic review and meta-analysis. J Intern Med. 2023;293:724\u201352.","journal-title":"J Intern Med"},{"key":"2232_CR27","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/nure.12127","volume":"72","author":"CA Marczinski","year":"2014","unstructured":"Marczinski CA, Fillmore MT. Energy drinks mixed with alcohol: what are the risks?. Nutr Rev. 2014;72:98\u2013107.","journal-title":"Nutr Rev"},{"key":"2232_CR28","doi-asserted-by":"crossref","unstructured":"McKetin R, Coen A, Kaye S. A comprehensive review of the effects of mixing caffeinated energy drinks with alcohol. Drug Alcohol Depend. 2015;151:15\u201330.","DOI":"10.1016\/j.drugalcdep.2015.01.047"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41386-025-02232-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41386-025-02232-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41386-025-02232-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T09:32:58Z","timestamp":1760347978000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41386-025-02232-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,17]]},"references-count":28,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["2232"],"URL":"https:\/\/doi.org\/10.1038\/s41386-025-02232-x","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,17]]},"assertion":[{"value":"2 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"JCS has received research related funding from Canopy Growth Corporation and DynamiCare Health and consulting fees from Realm of Caring Foundation and Merck Corporation in the past three years. TRS has received research funding from Cultivate Biologics and consulting fees from Canopy Growth in the past three years. MOBM is employed by Charlotte\u2019s Web, serves as a board member of DeFloria, and is a past employee of Canopy Growth Corporation. The remaining authors have nothing to disclose.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}